SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001047469-15-003716
Filing Date
2015-04-21
Accepted
2015-04-21 08:05:57
Documents
4
Period of Report
2015-06-10

Document Format Files

Seq Description Document Type Size
1 PRE 14A a2224358zpre14a.htm PRE 14A 419837
2 G719808.JPG g719808.jpg GRAPHIC 8483
3 G20682.JPG g20682.jpg GRAPHIC 11915
4 G189525.JPG g189525.jpg GRAPHIC 12205
  Complete submission text file 0001047469-15-003716.txt   466192
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-32966 | Film No.: 15781843
SIC: 2836 Biological Products, (No Diagnostic Substances)